In 2025, medical device manufacturers are grappling with heightened regulatory uncertainty, leading to slower reviews and communication difficulties with the FDA. This situation drives them to reassess operations for compliance and risk management, with a strong emphasis on maintaining product quality, which is vital for patient safety.
Why it Pays to Prioritize Quality Amid Regulatory Uncertainty
Related Posts
ATI Industrial Automation High-Speed Ethernet Module
The GBX 10 Gigabit Ethernet Module provides safe and reliable data transmission for advanced automation.
How to Sharpen Your FMEA Skills, Part 1
Employing FMEA (Failure Modes and Effects Analysis) ensures ongoing enhancements in processes and products. By preemptively tackling potential…